Terms: = Leukemia AND FES, FPS, 2242, ENSG00000182511, P07332 AND Treatment
23 results:
1. Drug repositioning of disulfiram induces endometrioid epithelial ovarian cancer cell death via the both apoptosis and cuproptosis pathways.
Gan Y; Liu T; Feng W; Wang L; Li LI; Ning Y
Oncol Res; 2023; 31(3):333-343. PubMed ID: 37305383
[TBL] [Abstract] [Full Text] [Related]
2. Identifying a novel ferroptosis-related prognostic score for predicting prognosis in chronic lymphocytic leukemia.
Pan B; Li Y; Xu Z; Miao Y; Yin H; Kong Y; Zhang X; Liang J; Xia Y; Wang L; Li J; Wu J; Xu W
Front Immunol; 2022; 13():962000. PubMed ID: 36275721
[TBL] [Abstract] [Full Text] [Related]
3. Infectious complications of induction treatment for acute myeloid leukaemia using the "7 + 3" protocol without antibiotic prophylaxis - 15 years of experience of one clinical site.
Cernan M; Szotkowski T; Hubacek J; Kolar M; Faber E; Indrak K; Papajik T
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2023 Sep; 167(3):236-245. PubMed ID: 35258041
[TBL] [Abstract] [Full Text] [Related]
4. Proton pump inhibitors selectively suppress MLL rearranged leukemia cells via disrupting MLL1-WDR5 protein-protein interaction.
Chen WL; Li DD; Chen X; Wang YZ; Xu JJ; Jiang ZY; You QD; Guo XK
Eur J Med Chem; 2020 Feb; 188():112027. PubMed ID: 31923859
[TBL] [Abstract] [Full Text] [Related]
5. Perturbation of Methionine/S-adenosylmethionine Metabolism as a Novel Vulnerability in MLL Rearranged leukemia.
Barve A; Vega A; Shah PP; Ghare S; Casson L; Wunderlich M; Siskind LJ; Beverly LJ
Cells; 2019 Oct; 8(11):. PubMed ID: 31717699
[TBL] [Abstract] [Full Text] [Related]
6. Retargeting CD19 Chimeric Antigen Receptor T Cells via Engineered CD19-Fusion Proteins.
Klesmith JR; Su L; Wu L; Schrack IA; Dufort FJ; Birt A; Ambrose C; Hackel BJ; Lobb RR; Rennert PD
Mol Pharm; 2019 Aug; 16(8):3544-3558. PubMed ID: 31242389
[TBL] [Abstract] [Full Text] [Related]
7. Role of Non Receptor Tyrosine Kinases in Hematological Malignances and its Targeting by Natural Products.
Siveen KS; Prabhu KS; Achkar IW; Kuttikrishnan S; Shyam S; Khan AQ; Merhi M; Dermime S; Uddin S
Mol Cancer; 2018 Feb; 17(1):31. PubMed ID: 29455667
[TBL] [Abstract] [Full Text] [Related]
8. Febrile events in acute lymphoblastic leukemia: a prospective observational multicentric SEIFEM study (SEIFEM-2012/B ALL).
Di Blasi R; Cattaneo C; Lewis RE; Tumbarello M; Angelici L; Dragonetti G; Busca A; Cambò B; Candoni A; Cesarini M; Cesaro S; Delia M; Fanci R; Farina F; Garzia M; Giordano A; Martino B; Melillo L; Nadali G; Perriello V; Picardi M; Quinto AM; Salutari P; Spolzino A; Vacca A; Vetro C; Zancanella M; Nosari A; Aversa F; Pagano L;
Ann Hematol; 2018 May; 97(5):791-798. PubMed ID: 29411126
[TBL] [Abstract] [Full Text] [Related]
9. Targeting protein-protein interaction between MLL1 and reciprocal proteins for leukemia therapy.
Wang ZH; Li DD; Chen WL; You QD; Guo XK
Bioorg Med Chem; 2018 Jan; 26(2):356-365. PubMed ID: 29254892
[TBL] [Abstract] [Full Text] [Related]
10. Dual inhibition of fes and Flt3 tyrosine kinases potently inhibits Flt3-ITD+ AML cell growth.
Weir MC; Hellwig S; Tan L; Liu Y; Gray NS; Smithgall TE
PLoS One; 2017; 12(7):e0181178. PubMed ID: 28727840
[TBL] [Abstract] [Full Text] [Related]
11. Percutaneous liver biopsy: retrospective study of primary and secondary hepatic lymphoma in twenty-one patients.
Bai YF; Liu JM; Zhang XM; Jiang CZ; Xu X; Zheng SS
Hepatobiliary Pancreat Dis Int; 2017 Feb; 16(1):58-64. PubMed ID: 28119260
[TBL] [Abstract] [Full Text] [Related]
12. Correlations of hematological parameters with bone marrow findings in chronic lymphoproliferative disorders associated with hepatitis viruses.
Ciufu C; Arama V; Bumbea H; Dobrea C; Ion I; Vladareanu AM
J Med Life; 2013; 6(4):464-71. PubMed ID: 24868264
[TBL] [Abstract] [Full Text] [Related]
13. Modern treatment in chronic lymphocytic leukemia: impact on survival and efficacy in high-risk subgroups.
Cuneo A; Cavazzini F; Ciccone M; Daghia G; Sofritti O; Saccenti E; Negrini M; Rigolin GM
Cancer Med; 2014 Jun; 3(3):555-64. PubMed ID: 24648042
[TBL] [Abstract] [Full Text] [Related]
14. Menin as a hub controlling mixed lineage leukemia.
Thiel AT; Huang J; Lei M; Hua X
Bioessays; 2012 Sep; 34(9):771-80. PubMed ID: 22829075
[TBL] [Abstract] [Full Text] [Related]
15. Inhibition of mitochondrial respiration and rapid depletion of mitochondrial glutathione by β-phenethyl isothiocyanate: mechanisms for anti-leukemia activity.
Chen G; Chen Z; Hu Y; Huang P
Antioxid Redox Signal; 2011 Dec; 15(12):2911-21. PubMed ID: 21827296
[TBL] [Abstract] [Full Text] [Related]
16. Long-term outcomes in patients with high-risk myeloid malignancies following matched related donor hematopoietic cell transplantation with myeloablative conditioning of BU, etoposide and CY.
Naik S; Wong R; Arai S; Brown J; Laport G; Lowsky R; Miklos D; Shizuru J; Blume K; Negrin R; Johnston L
Bone Marrow Transplant; 2011 Feb; 46(2):192-9. PubMed ID: 20498648
[TBL] [Abstract] [Full Text] [Related]
17. Tumour antigen-targeted immunotherapy for chronic myeloid leukaemia: is it still viable?
Riley CL; Mathieu MG; Clark RE; McArdle SE; Rees RC
Cancer Immunol Immunother; 2009 Sep; 58(9):1489-99. PubMed ID: 19259670
[TBL] [Abstract] [Full Text] [Related]
18. Chronic myelogenous leukemia: molecular and cellular aspects.
Pasternak G; Hochhaus A; Schultheis B; Hehlmann R
J Cancer Res Clin Oncol; 1998; 124(12):643-60. PubMed ID: 9879825
[TBL] [Abstract] [Full Text] [Related]
19. The effect of redox-related species of nitrogen monoxide on transferrin and iron uptake and cellular proliferation of erythroleukemia (K562) cells.
Richardson DR; Neumannova V; Nagy E; Ponka P
Blood; 1995 Oct; 86(8):3211-9. PubMed ID: 7579417
[TBL] [Abstract] [Full Text] [Related]
20. Antiapoptotic effect of c-fes protooncogene during granulocytic differentiation.
Ferrari S; Manfredini R; Tagliafico E; Grande A; Barbieri D; Balestri R; Pizzanelli M; Zucchini P; Citro G; Zupi G
Leukemia; 1994 Apr; 8 Suppl 1():S91-4. PubMed ID: 8152313
[TBL] [Abstract] [Full Text] [Related]
[Next]
